Immunobiology and Immune Therapy for Merkel Cell Carcinoma — PAUL NGHIEM (UNIVERSITY OF WASHINGTON)
OVERALL SUMMARY: IMMUNOBIOLOGY AND IMMUNE THERAPY FOR MERKEL CELL CARCINOMA Our Seattle-based MCC team, together with collaborators at several institutions, has played a leading role in characterizing
| Project title | Immunobiology and Immune Therapy for Merkel Cell Carcinoma |
|---|---|
| Project number | 5P01CA225517-03 |
| PI name | PAUL NGHIEM |
| Institution | UNIVERSITY OF WASHINGTON |
| Funding mechanism | P01 |
| Agency | NCI |
| Award amount | $2.99M |
| Fiscal year | 2021 |
| Project start | 2019-04-04T00:00:00 |
| Project end | 2024-03-31T00:00:00 |
| Abstract | OVERALL SUMMARY: IMMUNOBIOLOGY AND IMMUNE THERAPY FOR MERKEL CELL CARCINOMA Our Seattle-based MCC team, together with collaborators at several institutions, has played a leading role in characterizing |
| Key terms | <Accounting><Address><Adoptive Transfer><Affect><Affinity><Age><Antigens><Autoimmune><Avidity><B blo |
$799/mo
Try GrantRadar →